Patent · US Active

Isoform of the TGF-beta receptor II

US10233227B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 19, 2014
Grant dateMar 19, 2019
Priority date
Expiry dateDec 19, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16043
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An isoform of the TGF beta receptor II comprising a sequence of about of 80 amino acids and lacking a transmembrane domain; wherein the isoform is a TGFβ-1 agonist. The isoform comprises the amino acid sequence set forth in SEQ ID No. 12. The isoform may have the amino acid sequence set forth in SEQ ID No. 2 or sequences having at least 85% sequence identity to the sequence set forth in SEQ ID No. 2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.